Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of Enantiomeric Bupropion and Hydroxybupropion to Assess CYP2B6 Activity in Glomerular Kidney Diseases

UNC Libraries(2020)10.17615/crqs-3d95Source: DataRank Database

Use of Enantiomeric Bupropion and Hydroxybupropion to Assess CYP2B6 Activity in Glomerular Kidney Diseases is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (24)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kristi Stubbert,Evan D. Kharasch ORCID,Ronald J. Falk ORCID,Melanie S. Joy ORCID,Reginald F. Frye ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4298786314

National Institutes of Health

Grant: 7K24DA000417-07

Opioids in Cancer Pain &Drug Abuse: Optimizing Therapy

National Institutes of Health

Grant: 1K23DK064888-01A1

Pharmacokinetics &Genomics in Glomerular Diseases

National Institutes of Health

Grant: 3M01RR000046-39S2

STUDY OF CONTROLLED RELEASE DARIFENACINE IN TREATMENT OF IBS

FWCI

0.00

Citation Percentile

0.4%

greenLicense: Wiley Online Library User Agreement

repositoryhttps://doi.org/10.17615/crqs-3d95

https://doi.org/10.1177/0091270009353031

https://europepmc.org/articles/pmc3614080?pdf=render

https://dx.doi.org/10.17615/crqs-3d95

https://pubmed.ncbi.nlm.nih.gov/20103693

Fields of Study

Pharmacogenetics and Drug Metabolism03 medical and health sciences0302 clinical medicine

Keywords

BupropionPharmacologyCYP2B6MedicineChemistryInternal medicineCytochrome P450AdultMaleAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisOxidoreductases, N-DemethylatingStereoisomerismMiddle AgedLupus NephritisCytochrome P-450 CYP2B6PhenotypeChronic DiseaseAntidepressive Agents, Second-GenerationHumansFemaleAryl Hydrocarbon Hydroxylases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger